138 related articles for article (PubMed ID: 15508088)
1. Antibody-directed therapy for human hepatocellular carcinoma.
Mohr L; Yeung A; Aloman C; Wittrup D; Wands JR
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S225-31. PubMed ID: 15508088
[TBL] [Abstract][Full Text] [Related]
2. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro.
Moradpour D; Compagnon B; Wilson BE; Nicolau C; Wands JR
Hepatology; 1995 Nov; 22(5):1527-37. PubMed ID: 7590672
[TBL] [Abstract][Full Text] [Related]
3. Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system.
Mohr L; Schauer JI; Boutin RH; Moradpour D; Wands JR
Hepatology; 1999 Jan; 29(1):82-9. PubMed ID: 9862854
[TBL] [Abstract][Full Text] [Related]
4. Targeting a recombinant adenovirus vector to HCC cells using a bifunctional Fab-antibody conjugate.
Yoon SK; Mohr L; O'Riordan CR; Lachapelle A; Armentano D; Wands JR
Biochem Biophys Res Commun; 2000 Jun; 272(2):497-504. PubMed ID: 10833442
[TBL] [Abstract][Full Text] [Related]
5. [Status and prospect of antibody-directed targeting treatment for hepatocellular carcinoma].
Yang DH
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):380-1. PubMed ID: 15918978
[No Abstract] [Full Text] [Related]
6. Multiplicity of newly established monoclonal antibodies against hepatocellular carcinomas.
Ohzu K; Hasegawa K; Yamauchi K; Obata H
J Gastroenterol Hepatol; 1990; 5(6):601-7. PubMed ID: 1966596
[TBL] [Abstract][Full Text] [Related]
7. Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens.
Shouval D; Adler R
Prog Liver Dis; 1993; 11():251-67. PubMed ID: 8272514
[No Abstract] [Full Text] [Related]
8. A new murine monoclonal antibody against human hepatoma.
Stein R; Wang ZF; Sharkey RM; Klein KM; Goldenberg DM
Hybridoma; 1991 Apr; 10(2):255-67. PubMed ID: 1651901
[TBL] [Abstract][Full Text] [Related]
9. In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma.
Takahashi H; Ozturk M; Wilson B; Maki A; Ozawa K; Koizumi M; Endo K; Strauss W; Shouval D; Wands J
Hepatology; 1989 Apr; 9(4):625-34. PubMed ID: 2538386
[TBL] [Abstract][Full Text] [Related]
10. Gene Therapy for Hepatocellular Carcinoma Using Adenoviral Vectors Delivering a Gene Encoding IL-17A-Neutralizing Antibody Fragments.
Zou H; Tuhin IJ; Monty MA; Luo S; Shao J; Yan Z; Yu L
Hum Gene Ther; 2020 Oct; 31(19-20):1074-1085. PubMed ID: 32390483
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic strategies for hepatocellular carcinoma.
Butterfield LH
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S232-41. PubMed ID: 15508089
[TBL] [Abstract][Full Text] [Related]
12. Antigenic characterization of human hepatocellular carcinoma. Development of in vitro and in vivo immunoassays that use monoclonal antibodies.
Carlson RI; Ben-Porath E; Shouval D; Strauss W; Isselbacher KJ; Wands JR
J Clin Invest; 1985 Jul; 76(1):40-51. PubMed ID: 2991342
[TBL] [Abstract][Full Text] [Related]
13. Targeting of hepatoma cell and suppression of tumor growth by a novel 12mer peptide fused to superantigen TSST-1.
Jiang YQ; Wang HR; Li HP; Hao HJ; Zheng YL; Gu J
Mol Med; 2006; 12(4-6):81-7. PubMed ID: 16953561
[TBL] [Abstract][Full Text] [Related]
14. [Production and characterization of anti-human hepatocellular carcinoma monoclonal antibodies].
Peng H; Cao Z; Zhou S; Wang Z; Lei B; Zhao L
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(3):259-62. PubMed ID: 1965504
[TBL] [Abstract][Full Text] [Related]
15. Novel tumor-associated antigen of hepatocellular carcinoma defined by monoclonal antibody E4-65.
Zou K; Ju J; Xie H
Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):359-65. PubMed ID: 17492133
[TBL] [Abstract][Full Text] [Related]
16. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
17. Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.
Xiao Z; Chung H; Banan B; Manning PT; Ott KC; Lin S; Capoccia BJ; Subramanian V; Hiebsch RR; Upadhya GA; Mohanakumar T; Frazier WA; Lin Y; Chapman WC
Cancer Lett; 2015 May; 360(2):302-9. PubMed ID: 25721088
[TBL] [Abstract][Full Text] [Related]
18. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.
Yang LJ; Wang WL
World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620
[TBL] [Abstract][Full Text] [Related]
19. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel monoclonal antibody raised against human hepatocellular carcinoma.
Xie Y; Xie H
Hybridoma; 1998 Oct; 17(5):437-44. PubMed ID: 9873989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
